Drug Approval | June 01, 2022
FDA approves Roche’s Evrysdi for use in babies under two months with SMA
Evrysdi has proven efficacy in babies, children and adults with more than 5,000 patients treated to date
Evrysdi has proven efficacy in babies, children and adults with more than 5,000 patients treated to date
This agreement is in addition to the $92 million filling line expansion announced in November 2021
Dr Jitendra Singh said, the Biotech Park would act as a hub for incubation of new ideas
68% of patients receiving Kymriah in the ELARA trial experienced a complete response, with an 86% overall response rate, along with a remarkable safety profile
Researchers found that the drug combination led to a sustained and tenfold increase in the production of CD8 T cells and natural killer cells
Perrigo expects to launch Omeprazole Minis later this year
The centre works with active pharmaceutical ingredients (APIs) and can utilize innovative concepts with model APIs
The AI and technology upgrades allow doctors to choose their medical speciality and even spelling preferences to set their own speech model
Roche and its subsidiary TIB Molbiol have developed three different LightMix Modular Virus kits for the detection of the virus
Strategic partnership will develop a digital transformation roadmap and create opportunities for co-innovation in healthcare technologies
Subscribe To Our Newsletter & Stay Updated
